BIO2022 being followed up with more media work. I get a sense there is now a push to spread the word on a scale not done before. Infections front and centre of the news headlines around the world, and Recce now has compelling data that their drug is safe and tolerable for the biggest unmet medical need in the world.
I suspect a game plan of raising the profile, get more eyes following their progress now, and then drop a burns results announcement that will rerate the Company
BIO2022 being followed up with more media work. I get a sense...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.0¢ | $21.54K | 57.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3248 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 49884 | 1 |
View Market Depth
| Last trade - 14.27pm 30/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |